Loading insider details...
Beta
Latest Form 4 (Feb 20, 2026): Grant/Award of 45,559 EOLS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Evolus, Inc. (EOLS) | Grant/Award | 45,559 | n/a |
| Mar 11, 2025 | Evolus, Inc. (EOLS) | Grant/Award | 7,364 | n/a |
| Jun 13, 2024 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/Award | 3,495 | n/a |
| May 15, 2024 | Evolus, Inc. (EOLS) | Sale | 3,643 | $46.4K |
| Feb 9, 2024 | Evolus, Inc. (EOLS) | Grant/Award | 6,464 | n/a |
| Feb 1, 2023 | Evolus, Inc. (EOLS) | Grant/Award | 8,293 | n/a |
| May 17, 2022 | Evolus, Inc. (EOLS) | Sale | 5,313 | $69.6K |
| Jan 27, 2022 | Evolus, Inc. (EOLS) | Grant/Award | 15,568 | n/a |
| Feb 9, 2021 | Evolus, Inc. (EOLS) | Grant/Award | 19,313 | n/a |
| Jan 25, 2020 | Evolus, Inc. (EOLS) | Grant/Award | 23,458 | n/a |